sb 203580 has been researched along with oridonin in 3 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (oridonin) | Trials (oridonin) | Recent Studies (post-2010) (oridonin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 465 | 0 | 349 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, J; Ikejima, T; Onodera, S; Tashiro, S; Wu, L | 1 |
Cui, Q; Ikejima, T; Minami, M; Onodera, S; Tashiro, S | 1 |
Bu, HQ; Chen, L; Cui, JH; Huang, H; Li, Y; Liu, DL; Wei, WT | 1 |
3 other study(ies) available for sb 203580 and oridonin
Article | Year |
---|---|
Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Bisbenzimidazole; Blotting, Western; Caspases; Cell Cycle; Cell Line, Tumor; Clone Cells; Diterpenes; Diterpenes, Kaurane; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fibrosarcoma; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, p53; Imidazoles; Mice; Phosphorylation; Pyridines; Tumor Suppressor Protein p53 | 2005 |
Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation.
Topics: Adenine; Anthracenes; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blotting, Western; Cadaverine; Diterpenes; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Flow Cytometry; HeLa Cells; Humans; Imidazoles; Isodon; JNK Mitogen-Activated Protein Kinases; Membrane Proteins; Microtubule-Associated Proteins; p38 Mitogen-Activated Protein Kinases; Polyenes; Polyunsaturated Alkamides; Pyridines; ras Proteins | 2007 |
Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Topics: Anthracenes; Apoptosis; Benzothiazoles; Caspase 3; Caspase 9; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diterpenes, Kaurane; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; G1 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Isodon; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Phosphorylation; Plant Preparations; Pyridines; RNA, Messenger; Toluene; Tumor Suppressor Protein p53 | 2014 |